Page results
-
Information about the Integrated Women's Service at the RLHIM patient information leaflet
-
Information about the Integrated Children and Adolescent Service at the RLHIM
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH and Whittington Health have a long history of working together to benefit patients, staff and our communities across Camden, Haringey, Islington and beyond. This includes services such as the virtual ward, orthopaedic surgery and paediatric dentistry.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
UCLH has treated the first brain cancer patient with immunotherapy prior to standard treatment as part of a pioneering trial.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
-
Information about the Integrated Cancer Care Service for children and young adults at the RLHIM.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
File results
-
FOI/2022/0252 - Translation services
-
FOI/2022/0253 - TB patient demographics
-
FOI/2022/0254 - Patient treatment/ surgery
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0267 - Performance data for the CCG2 CQUIN - Antibiotic prescribing for UTI in adults aged 16+
-
FOI/2022/0270 - Local care record/ shared care record implementation
-
FOI/2022/0274 - Patient treatment for various conditions
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0278 - Surgical tables in use at Trust